Staffers in the Trump White House tried to pressure the @US_FDA into reauthorizing the anti-malaria drug hydroxychloroquine after it had been discredited as a COVID-19 treatment, according to a new congressional report. https://t.co/B1ZLI0x4RU

— Matthew Perrone (@AP_FDAwriter) August 24, 2022